Showing 1 - 1 of 1 Prostate Cancers
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Status: Enrolling

Investigator: Jorge Darcourt

Study Coordinator: Pej Hemati

Phone: 713.441.3926

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. ... Read more >

Live Chat Available